Schroder Investment Management Group
ALT icon

Schroder Investment Management Group’s Altimmune ALT Stock Holding History

Schroder Investment Management Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Buy
667,837
+198,824
+42% +$844K ﹤0.01% 938
2025
Q4 		$1.69M Buy
+469,013
New +$2.04M ﹤0.01% 912
2025
Q2 		– Sell
-961,884
Closed -$5.12M – 1157
2025
Q1 		$5.12M Buy
961,884
+533,563
+125% +$3.38M 0.01% 753
2024
Q4 		$3.14M Sell
428,321
-45,544
-10% -$348K ﹤0.01% 857
2024
Q3 		$3.07M Hold
473,865
– – ﹤0.01% 880
2024
Q2 		$3.15M Buy
473,865
+283,041
+148% +$2.09M ﹤0.01% 869
2024
Q1 		$1.94M Buy
+190,824
New +$1.94M ﹤0.01% 928

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Schroder Investment Management Group's ALT Position: Q1 2026 in Review

Schroder Investment Management Group increased its Altimmune (ALT) stake by 42% in Q1 2026, buying an estimated $844K and bringing the position to 667,837 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Schroder Investment Management Group first reported a position in ALT in Q1 2024 and has held it in 7 quarters since. The position peaked at $5.12M in Q1 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Schroder Investment Management Group held 667,837 shares of Altimmune worth $1.92M as of Q1 2026.
  • Schroder Investment Management Group bought 198,824 Altimmune shares in Q1 2026, an estimated $844K.
  • Altimmune made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #938 holding.
  • Schroder Investment Management Group first reported a position in Altimmune in Q1 2024 and has held it in 7 quarters since.
  • Schroder Investment Management Group's Altimmune position peaked at $5.12M in Q1 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.